multi-4SCAR-T therapy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for multi-4SCAR-T therapy, covering 2020-06-12 to 2020-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Multi-4SCAR-T Therapy Targeting Breast Cancer [Phase 1, Phase 2]